February 16, 2017
894
5
0.56%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
55:00Now PlayingHeart patients rejoice. Angioplasties are set to become cheaper with the NPPA or National Pharmaceutical Pricing Authority slashing prices of life-saving coronary stents by 85% to Rs 29,600. Till this order came about, a stent cost between 40,000 to 2 lakh rupees. While patients and public health organizations are naturally enthused, the industry is in a state of shock. To discuss this, Magicbricks NOW caught up with Sanjeev Mehta, Pulmonologist, Lilavati Hospital; DR. B. K. Goyal, Cardiologist, Mumbai Hospital; Dr. Gurinder Grewal, Former President, Punjab Medical Council; Malini Aisola, All India drugs Network; Probir Das, Chair of Medical Devices, FICCI; Rajiv Nath, Forum Coordinator, Association of Indian Medical Devices Industry; Ganesh Sabat, CEO, Sahajanand Medical Technology, First Indian Company to Commercialise Stent. Watch the entire video to know more:
Be Un Confused
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.